首页> 外国专利> A method for the diagnosis of Alzheimers disease from determination of PGCP concentration in human plasma

A method for the diagnosis of Alzheimers disease from determination of PGCP concentration in human plasma

机译:通过测定人血浆中PGCP的浓度来诊断阿尔茨海默氏病的方法

摘要

PURPOSE: A method for diagnosing dementia through measurement of PGCP concentrate in plasma is provided to simply diagnose dementia. CONSTITUTION: A kit for diagnosing dementia contains anti-PGCP(plasma glutamate carboxypeptidase) antibody. The anti-PGCP antibody is conjugated on a ligand. The ligand is biotin or biotin derivative which binds to avidin or streptavidin. The kit additionally comprises a visualization conjugate conjugated with chromogenic enzyme, chromogenic material or fluorescent molecule. The chromogenic enzyme is HRP(horseradish peroxidase) or alkaline phosphatase. The chromogenic material is colloid gold. The fluorescent molecule is FITC(poly L-lysine-fluorescein isothiocyanate) and RITC(rhodamine-Bisothiocyanate).
机译:目的:提供一种通过测量血浆中PGCP浓缩物来诊断痴呆的方法,以简单地诊断痴呆。构成:用于诊断痴呆的试剂盒包含抗PGCP(血浆谷氨酸羧肽酶)抗体。抗PGCP抗体缀合在配体上。配体是与抗生物素蛋白或抗生蛋白链菌素结合的生物素或生物素衍生物。该试剂盒还包括与显色酶,显色材料或荧光分子缀合的可视化缀合物。生色酶是HRP(辣根过氧化物酶)或碱性磷酸酶。发色材料是胶体金。荧光分子是FITC(聚L-赖氨酸-荧光素异硫氰酸酯)和RITC(若丹明-异硫氰酸酯)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号